Sartorius Stedim Biotech Aktie
174,90
EUR
-0,40
EUR
-0,23
%
175,00
EUR
-0,20
EUR
-0,11
%
Werbung
Sartorius Stedim Biotech Aktie Analyse
08.07.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
06.06.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
16.04.25 | Sartorius Stedim Biotech Market-Perform | Bernstein Research | |
29.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
24.01.25 | Sartorius Stedim Biotech Neutral | UBS AG | |
22.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
03.10.24 | Sartorius Stedim Biotech Neutral | UBS AG | |
27.06.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
Werbung
|
|||
23.04.24 | Sartorius Stedim Biotech Equal Weight | Barclays Capital | |
11.08.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group | |
18.04.23 | Sartorius Stedim Biotech Neutral | Credit Suisse Group |
Werbung
Werbung